Cd20 binding agents and uses thereof

Jan Tavernier; Johan Van Der Heyden; Nick Devoogdt; Matthias D'Huyvetter; Ahmet Krasniqi

Cd20 binding agents and uses thereof

Jan Tavernier (Uitvinder), Johan Van Der Heyden (Uitvinder), Nick Devoogdt (Uitvinder), Matthias D'Huyvetter (Uitvinder), Ahmet Krasniqi (Uitvinder)

Onderzoeksoutput: Patent

Samenvatting

The present disclosure relates to radiolabeled binding agents (e.g. antibodies, such as, without limitation, single-domain antibodies) which bind CD20 and their use as diagnostic, prognostic, predictive and therapeutic agents.

Originele taal-2	English
Octrooinummer	WO2017153345
Status	Published - 2017

Handle.net

Permanente koppeling

Andere bestanden en links

https://worldwide.espacenet.com/patent/search/family/055484929/publication/WO2017153345A1?q=WO2017153345

IWT710: Gerichte radionuclidentherapie van non-hodgkin lymfoom met anti-CD20 nanobodies
Devoogdt, N. (Administrative Promotor) & Krasniqi, A. (Mandataris)
1/01/15 → 31/12/18
Project: Fundamenteel

Citeer dit

@misc{3aa2a816281f48c08e4b91f99198f649,

title = "Cd20 binding agents and uses thereof",

abstract = "The present disclosure relates to radiolabeled binding agents (e.g. antibodies, such as, without limitation, single-domain antibodies) which bind CD20 and their use as diagnostic, prognostic, predictive and therapeutic agents.",

author = "Jan Tavernier and {Van Der Heyden}, Johan and Nick Devoogdt and Matthias D'Huyvetter and Ahmet Krasniqi",

year = "2017",

language = "English",

type = "Patent",

note = "WO2017153345",

}

TY - PAT

T1 - Cd20 binding agents and uses thereof

AU - Tavernier, Jan

AU - Van Der Heyden, Johan

AU - Devoogdt, Nick

AU - D'Huyvetter, Matthias

AU - Krasniqi, Ahmet

PY - 2017

Y1 - 2017

N2 - The present disclosure relates to radiolabeled binding agents (e.g. antibodies, such as, without limitation, single-domain antibodies) which bind CD20 and their use as diagnostic, prognostic, predictive and therapeutic agents.

AB - The present disclosure relates to radiolabeled binding agents (e.g. antibodies, such as, without limitation, single-domain antibodies) which bind CD20 and their use as diagnostic, prognostic, predictive and therapeutic agents.

UR - https://worldwide.espacenet.com/patent/search/family/055484929/publication/WO2017153345A1?q=WO2017153345

M3 - Patent

M1 - WO2017153345

ER -

Cd20 binding agents and uses thereof

Samenvatting

Handle.net

Andere bestanden en links

Vingerafdruk

Projecten

IWT710: Gerichte radionuclidentherapie van non-hodgkin lymfoom met anti-CD20 nanobodies

Citeer dit